| Evaluation of Trigeminal Nerve Blockade (NCT03632044) | University of Florida | 2018-11-20 |
| Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study (NCT04958356) | University of Helsinki | 2018-11-19 |
| Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM (NCT03673826) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2018-11-19 |
| Effects of Telemonitoring on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation (NCT03358303) | University Health Network, Toronto | 2018-11-16 |
| A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC (NCT02905591) | Joseph J. Cullen, MD, FACS | 2018-11-16 |
| Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC (NCT03732677) | AstraZeneca | 2018-11-16 |
| Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor (NCT03607890) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-16 |
| Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment (NCT03731585) | M.D. Anderson Cancer Center | 2018-11-15 |
| Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial (NCT03712605) | National Cancer Institute (NCI) | 2018-11-15 |
| Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) (NCT03698994) | National Cancer Institute (NCI) | 2018-11-14 |
| Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia (NCT03513484) | Northwestern University | 2018-11-14 |
| LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma (NCT03684980) | Memorial Sloan Kettering Cancer Center | 2018-11-14 |
| SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma (NCT03546582) | RTOG Foundation, Inc. | 2018-11-14 |
| Does Cognitive Status Affect Pulmonary Rehabilitation Gains? (NCT03740867) | Istanbul Medipol University Hospital | 2018-11-13 |
| Gene Therapy for Children With CLN3 Batten Disease (NCT03770572) | Neela Therapeutics | 2018-11-13 |
| Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer (NCT03573648) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-13 |
| Hypofractionated Regional Nodal Irradiation in Breast Cancer (NCT06443359) | Corewell Health East | 2018-11-13 |
| Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant (NCT04160390) | City of Hope Medical Center | 2018-11-13 |
| Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma (NCT03743662) | Memorial Sloan Kettering Cancer Center | 2018-11-12 |
| rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers (NCT03865472) | Roswell Park Cancer Institute | 2018-11-10 |
| Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type (NCT03728972) | Memorial Sloan Kettering Cancer Center | 2018-11-09 |
| Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial (NCT03584022) | Mayo Clinic | 2018-11-09 |
| Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS (NCT03802799) | Zynerba Pharmaceuticals, Inc. | 2018-11-09 |
| Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. (NCT03704480) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2018-11-09 |
| Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight (NCT04002440) | University of California, San Diego | 2018-11-08 |
| MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC (NCT03881605) | Sunnybrook Health Sciences Centre | 2018-11-08 |
| Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases (NCT03741673) | M.D. Anderson Cancer Center | 2018-11-08 |
| Winter-Swimming and Brown Adipose Tissue Activity in Middel-aged Obese Subjects (WinterBAT). (NCT03541096) | Kristian Karstoft | 2018-11-07 |
| Clinic-Based Financial Coaching and Family Health and Development (NCT03736590) | University of California, Los Angeles | 2018-11-07 |
| Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System (NCT03620942) | KK Women's and Children's Hospital | 2018-11-07 |
| Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle" (NCT03588299) | Bayer | 2018-11-07 |
| Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3) (NCT03795311) | Centre Georges Francois Leclerc | 2018-11-07 |
| A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (NCT03734237) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2018-11-06 |
| Early Weight-Bearing After the Lapiplasty Procedure (NCT03740282) | Treace Medical Concepts, Inc. | 2018-11-06 |
| A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer (NCT03661320) | Bristol-Myers Squibb | 2018-11-06 |
| Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations (NCT03581292) | National Cancer Institute (NCI) | 2018-11-06 |
| Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study (NCT03667404) | Northwestern University | 2018-11-06 |
| Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy (NCT03712566) | University Health Network, Toronto | 2018-11-06 |
| Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients (NCT03686007) | City of Hope Medical Center | 2018-11-06 |
| DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC (NCT03716180) | Dana-Farber Cancer Institute | 2018-11-05 |
| Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA (NCT03608579) | Mayo Clinic | 2018-11-05 |
| A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy (NCT03570931) | Biojiva LLC | 2018-11-05 |
| In-Utero Endoscopic Correction of Spina Bifida (NCT04362592) | University of Southern California | 2018-11-02 |
| Eltrombopag for People With Fanconi Anemia (NCT03206086) | National Heart, Lung, and Blood Institute (NHLBI) | 2018-11-02 |
| Cognitive Changes and Neural Correlates After Rehabilitation of Masticatory Function in Elderly -an Intervention Study (NCT04458207) | Folktandvården Stockholms län AB | 2018-11-02 |
| CHORUS - Comprehensive HHT Outcomes Registry of the United States (Formerly OUR HHT Registry) (NCT04150822) | Unity Health Toronto | 2018-11-01 |
| Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia (NCT03672201) | Centre for Addiction and Mental Health | 2018-11-01 |
| Perthes Disease in Norway (NCT03885960) | Oslo University Hospital | 2018-11-01 |
| Airway Management of Pediatric Patients With Klippel-Feil Syndrome (NCT03741790) | Boston Children's Hospital | 2018-11-01 |
| Brain-based Understanding of Individual Language Differences After Stroke (NCT04991519) | Georgetown University | 2018-11-01 |
| VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer (NCT03690986) | Emory University | 2018-11-01 |
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery (NCT03317405) | National Cancer Institute (NCI) | 2018-10-31 |
| Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (NCT03732820) | AstraZeneca | 2018-10-31 |
| Destination Therapy Post Approval Study (NCT03681210) | Medtronic Cardiac Rhythm and Heart Failure | 2018-10-31 |
| Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer (NCT03672773) | Jonsson Comprehensive Cancer Center | 2018-10-31 |
| Early CMR in Acute MI (NCT07602439) | The Affiliated Hospital of Xuzhou Medical University | 2018-10-31 |
| Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer (NCT03814252) | Turku University Hospital | 2018-10-30 |
| A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease (NCT03705234) | University of Oxford | 2018-10-30 |
| Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab (NCT03653052) | Simon C Pacey, MD | 2018-10-30 |
| Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib (NCT03235245) | European Organisation for Research and Treatment of Cancer - EORTC | 2018-10-30 |
| Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE) (NCT03707743) | IRCCS San Raffaele | 2018-10-30 |
| A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee (NCT03203330) | Kolon TissueGene, Inc. | 2018-10-30 |
| Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry (NCT07136324) | The University of Texas Health Science Center, Houston | 2018-10-30 |
| Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study (NCT03635424) | Medtronic Cardiovascular | 2018-10-30 |
| Intrathecal Rituximab With Standard Intrathecal Prophylaxis to Prevent CNS Relapse for CD 20+ Non Hodgkin Lymphoma (NCT03688451) | Tahir Latif | 2018-10-29 |
| Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer (NCT03904173) | Oslo University Hospital | 2018-10-29 |
| A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (NCT03596645) | Janssen Research & Development, LLC | 2018-10-29 |
| Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL (NCT03602157) | UNC Lineberger Comprehensive Cancer Center | 2018-10-29 |
| Shaving Satisfaction in Males With Skin Irritation From Shaving (NCT03569956) | Wake Forest University Health Sciences | 2018-10-29 |
| Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101 (NCT03741127) | Poseida Therapeutics, Inc. | 2018-10-29 |
| National Register of Actionable Mutations (NCT05918666) | Federation of Italian Cooperative Oncology Groups | 2018-10-27 |
| Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer (NCT03601455) | Jonsson Comprehensive Cancer Center | 2018-10-26 |
| Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors (NCT03375320) | National Cancer Institute (NCI) | 2018-10-26 |
| ABC-Scores for Reduction of Stroke and Mortality in Atrial Fibrillation - The ABC-AF Study (NCT03753490) | Uppsala University | 2018-10-25 |
| Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images (NCT03694145) | Charles Drew University of Medicine and Science | 2018-10-25 |
| Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia (NCT03654768) | SWOG Cancer Research Network | 2018-10-24 |
| Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN (NCT03613532) | Jacqueline Garcia, MD | 2018-10-24 |
| PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) (NCT03663218) | Weill Medical College of Cornell University | 2018-10-24 |
| Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy (NCT03725761) | University of Wisconsin, Madison | 2018-10-24 |
| Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (NCT03643133) | UNICANCER | 2018-10-23 |
| The Right Treatment for the Right Patient At the Right Time. a Study Following 5,000 Patients with Knee Osteoarthritis (NCT03746184) | Hvidovre University Hospital | 2018-10-23 |
| Traditional Versus Alternative Alignment in TKR (NCT03196011) | Royal Devon and Exeter NHS Foundation Trust | 2018-10-23 |
| Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder (NCT03713983) | Johan Franck | 2018-10-23 |
| Comparing No Mechanical Bowel Preparation With Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery (NCT03663504) | Ottawa Hospital Research Institute | 2018-10-23 |
| Conditioning SCID Infants Diagnosed Early (NCT03619551) | Center for International Blood and Marrow Transplant Research | 2018-10-22 |
| Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma (NCT03704662) | Medical College of Wisconsin | 2018-10-22 |
| Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years (NCT03742297) | PETHEMA Foundation | 2018-10-22 |
| AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma (NCT03668340) | Dana-Farber Cancer Institute | 2018-10-22 |
| A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma. (NCT03539744) | AbbVie | 2018-10-22 |
| Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia (NCT03709719) | Assistance Publique - Hôpitaux de Paris | 2018-10-20 |
| Cervical Radiculopathy Trial (NCT03674619) | Oslo University Hospital | 2018-10-19 |
| People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents (NCT03520660) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2018-10-19 |
| Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7) (NCT03617731) | University of Heidelberg Medical Center | 2018-10-18 |
| Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer (NCT03637543) | Beth Israel Deaconess Medical Center | 2018-10-18 |
| Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence (NCT03438552) | UNICANCER | 2018-10-18 |
| Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation. (NCT03630614) | Assistance Publique - Hôpitaux de Paris | 2018-10-17 |
| Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML (NCT03709758) | Dana-Farber Cancer Institute | 2018-10-17 |
| Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer (NCT03982485) | RenJi Hospital | 2018-10-16 |
| A Study of Cognitive Changes in Patients Receiving Brain Radiation (NCT04390906) | University of Rochester | 2018-10-16 |
| CoreHip - Post Market Clinical Follow-Up Study (NCT03685110) | Aesculap AG | 2018-10-16 |